Saturday 17 October 2026 Export NIKI’s income statement to Excel — free account

Niki BioSolutions, Inc.

NIKI Healthcare Biotechnology

Niki BioSolutions, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $431,400.00, down 66.7% from fiscal 2022.

2.03 0.19 −8.56%

Follow NIKI

Alert me

Market cap: $6.9M
P/E: 0.0×
Fwd P/E: 31.9×
Dividend yield: —
F-score: 2/9
Altman Z: −5.03
Beneish M: −1.39
Dividend safety: n/a

Overview Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Dec '24	Jun '25	Sep '25	Dec '25
ROE Full definition →	+8 more TTM periods Free account	0.00%	0.00%	0.00%	0.00%
ROA Full definition →		0.00%	0.00%	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow Full definition →		(16.25)	(11.01)	(3.77)	(2.90)
Capital Expenditures Full definition →		0.14	—	—	0.13
Other line items
Cash ROIC Full definition →		(102.24%)	(55.46%)	(20.05%)	(14.05%)
Accounts Receivable Turnover Full definition →		0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		0.00	0.00	0.00	0.00
Depreciation/Fixed assets Full definition →		0.48	—	—	0.00
Capex/Depreciation Full definition →		0.06	—	—	0.08
Operating CF per Share Full definition →		0.00	0.00	0.00	0.00
Capex per Share Full definition →		0.00	—	—	0.00
Capex to Sales Full definition →		0.00	—	—	0.00

Show all line items

Columns are period end dates · fundamentals updated 5 Oct 2026